Personalized Cancer Chemotherapy

Personalized Cancer Chemotherapy separately describes and addresses "individualized cancer chemotherapy" (ICC) strategies new and old, to provide readers with new insights into their characteristics and techniques, as well as key debates and future trends in this area. The book devotes chapters to drug sensitivity testing, cancer biomarkers and bioinformatics detection, pharmacogenetics, individualized antimetastatic therapy, drug combinations, assistant chemotherapy, and cost-effectiveness considerations. A major obstacle to controlling cancer growth and metastases in patients is the inappropriate use of anticancer and antimetastatic drugs. Researchers and clinicians are now beginning to focus on ICC also called "personalized cancer chemotherapy" (PCC), to improve therapeutic quality and outcomes by selecting and prescribing the most appropriate and effective drugs. Using genetic, molecular, and bioinformatics data and modern experimental techniques, known tumor genes can be detected more easily than ever before; the average speed of genetic sequencing has increased 15,000 to 50,000 times since the Human Geonme Project was completed. This book will help readers understand the pros and cons of each individualized cancer chemotherapy strategy from different angles so as to make good judgments and predictions of drug responses and clinical outcomes. Explores the central components of cancer treatment Investigates new developments in cancer treatment Discusses the many strategies of individualized cancer chemotherapy

Produk Detail:

  • Author : Da Yong Lu
  • Publisher : Woodhead Publishing
  • Pages : 84 pages
  • ISBN : 0081003471
  • Rating : 4/5 from 21 reviews
CLICK HERE TO GET THIS BOOKPersonalized Cancer Chemotherapy

Personalized Cancer Chemotherapy

Personalized Cancer Chemotherapy
  • Author : Da Yong Lu
  • Publisher : Woodhead Publishing
  • Release : 05 December 2014
GET THIS BOOKPersonalized Cancer Chemotherapy

Personalized Cancer Chemotherapy separately describes and addresses "individualized cancer chemotherapy" (ICC) strategies new and old, to provide readers with new insights into their characteristics and techniques, as well as key debates and future trends in this area. The book devotes chapters to drug sensitivity testing, cancer biomarkers and bioinformatics detection, pharmacogenetics, individualized antimetastatic therapy, drug combinations, assistant chemotherapy, and cost-effectiveness considerations. A major obstacle to controlling cancer growth and metastases in patients is the inappropriate use of anticancer and antimetastatic

Customized Cancer Treatment

Customized Cancer Treatment
  • Author : Ralph W. Moss
  • Publisher : Unknown Publisher
  • Release : 09 May 2021
GET THIS BOOKCustomized Cancer Treatment

Customized Cancer Treatment is the first book for the layperson on chemosensitivity testing. This is a laboratory procedure by which patients and their doctors can discover which drugs are mostly like to work for them and which to avoid. Chemosensitivity testing is very effective at finding the best drugs for each individual. It is a form of personalized treatment. According to Dr. Robert Nagourney, No cancer patient should begin treatment without first reading this book.

Personalized Treatment of Breast Cancer

Personalized Treatment of Breast Cancer
  • Author : Masakazu Toi,Eric Winer,John Benson,Suzanne Klimberg
  • Publisher : Springer
  • Release : 24 May 2016
GET THIS BOOKPersonalized Treatment of Breast Cancer

This book deals with the essential factors in the personalization of treatment for primary breast cancer. These include host issues, lymph node surgery, radiation therapy, and preoperative systemic treatment requiring specialized knowledge, multidisciplinary care experience, techniques, and research. Locoregional treatment in conjunction with systemic treatments is another important factor, with options for local therapy significantly affected by genetic BRCA mutation. Axillary treatment issues have become top priorities in recent primary breast cancer care, and these are highlighted in the book’

Precision Medicine in Oncology

Precision Medicine in Oncology
  • Author : Bulent Aydogan,James A. Radosevich
  • Publisher : John Wiley & Sons
  • Release : 23 September 2020
GET THIS BOOKPrecision Medicine in Oncology

A FRESH EXAMINATION OF PRECISION MEDICINE'S INCREASINGLY PROMINENT ROLE IN THE FIELD OF ONCOLOGY Precision medicine takes into account each patient's specific characteristics and requirements to arrive at treatment plans that are optimized towards the best possible outcome. As the field of oncology continues to advance, this tailored approach is becoming more and more prevalent, channelling data on genomics, proteomics, metabolomics and other areas into new and innovative methods of practice. Precision Medicine in Oncology draws together the essential research

Cancer Genetics and Genomics for Personalized Medicine

Cancer Genetics and Genomics for Personalized Medicine
  • Author : Il-Jin Kim
  • Publisher : CRC Press
  • Release : 11 April 2017
GET THIS BOOKCancer Genetics and Genomics for Personalized Medicine

This book covers almost all fields of cancer genetics and genomics for personalized medicine. Targeted therapy, or precision medicine, or personalized medicine is becoming a standard treatment for many diseases, including cancer. However, how much do we know about the personalized medicine approach? This lucid book helps undergraduate and graduate students, professional researchers, and clinicians to better understand the key concept of personalized medicine. The most up-to-date topics on personalized medicine in this book cover the recent trends in and

The Death of Cancer

The Death of Cancer
  • Author : Vincent T. DeVita, Jr., M.D.,Elizabeth DeVita-Raeburn
  • Publisher : Sarah Crichton Books
  • Release : 03 November 2015
GET THIS BOOKThe Death of Cancer

Cancer touches everybody’s life in one way or another. But most of us know very little about how the disease works, why we treat it the way we do, and the personalities whose dedication got us where we are today. For fifty years, Dr. Vincent T. DeVita Jr. has been one of those key players: he has held just about every major position in the field, and he developed the first successful chemotherapy treatment for Hodgkin’s lymphoma, a

Lung Cancer and Personalized Medicine: Novel Therapies and Clinical Management

Lung Cancer and Personalized Medicine: Novel Therapies and Clinical Management
  • Author : Aamir Ahmad,Shirish M. Gadgeel
  • Publisher : Springer
  • Release : 24 December 2015
GET THIS BOOKLung Cancer and Personalized Medicine: Novel Therapies and Clinical Management

This, the second of two volumes on personalized medicine in lung cancer, touches upon the recent progress in targeted drug development based on genomics; emerging biomarkers and therapeutic targets such as EMT, cancer stem cells, and the tumor microenvironment; current personalized clinical management and radiation therapy for lung cancers; and the promise of epigenetics and next-generation sequencing for the advancements towards personalized therapy of lung cancer patients. With chapters on state-of-the-art therapies and technologies written by leading experts working to

Pharmacogenetics of Breast Cancer

Pharmacogenetics of Breast Cancer
  • Author : Brian Leyland-Jones
  • Publisher : CRC Press
  • Release : 27 April 2020
GET THIS BOOKPharmacogenetics of Breast Cancer

Pharmacogenetics is becoming increasingly relevant in the diagnosis, treatment, and recovery of cancer patients. A major problem facing oncologists is the outstanding varied efficacy of treatment. Promising advances in pharmacogenetics have allowed the development of effective agents which will enable personalized cancer chemotherapy to become rout

Precision Medicine in Cancer Therapy

Precision Medicine in Cancer Therapy
  • Author : Daniel D. Von Hoff,Haiyong Han
  • Publisher : Springer
  • Release : 17 June 2019
GET THIS BOOKPrecision Medicine in Cancer Therapy

This book presents the latest advances in precision medicine in some of the most common cancer types, including hematological, lung and breast malignancies. It also discusses emerging technologies that are making a significant impact on precision medicine in cancer therapy. In addition to describing specific approaches that have already entered clinical practice, the book explores new concepts and tools that are being developed. Precision medicine aims to deliver personalized healthcare tailored to a patient’s genetics, lifestyle and environment, and

Drug Repurposing in Cancer Therapy

Drug Repurposing in Cancer Therapy
  • Author : Kenneth K.W. To,William C.S. Cho
  • Publisher : Academic Press
  • Release : 29 July 2020
GET THIS BOOKDrug Repurposing in Cancer Therapy

Drug Repurposing in Cancer Therapy: Approaches and Applications provides comprehensive and updated information from experts in basic science research and clinical practice on how existing drugs can be repurposed for cancer treatment. The book summarizes successful stories that may assist researchers in the field to better design their studies for new repurposing projects. Sections discuss specific topics such as in silico prediction and high throughput screening of repurposed drugs, drug repurposing for overcoming chemoresistance and eradicating cancer stem cells, and

Delivering Affordable Cancer Care in the 21st Century

Delivering Affordable Cancer Care in the 21st Century
  • Author : Institute of Medicine,Board on Health Care Services,National Cancer Policy Forum
  • Publisher : National Academies Press
  • Release : 20 June 2013
GET THIS BOOKDelivering Affordable Cancer Care in the 21st Century

Rising health care costs are a central fiscal challenge confronting the United States. National spending on health care currently accounts for 18 percent of gross domestic product (GDP), but is anticipated to increase to 25 percent of GDP by 2037. The Bipartisan Policy Center argues that "this rapid growth in health expenditures creates an unsustainable burden on America's economy, with far-reaching consequences". These consequences include crowding out many national priorities, including investments in education, infrastructure, and research; stagnation of employee wages; and decreased

Lung Cancer and Personalized Medicine

Lung Cancer and Personalized Medicine
  • Author : Aamir Ahmad,Shirish Gadgeel
  • Publisher : Springer
  • Release : 14 December 2015
GET THIS BOOKLung Cancer and Personalized Medicine

This, the first of two volumes on personalized medicine in lung cancer, touches on the core issues related to the understanding of lung cancer—statistics and epidemiology of lung cancer—along with the incidence of lung cancer in non-smokers. A major focus of this volume is the state of current therapies against lung cancer—immune, targeted therapies against EGFR TKIs, KRAS, ALK, angiogenesis; the associated challenges, especially resistance mechanisms; and recent progress in targeted drug development based on metal chemistry.

Personalized Management of Gastric Cancer

Personalized Management of Gastric Cancer
  • Author : Jia Wei,Baorui Liu
  • Publisher : Springer
  • Release : 15 May 2017
GET THIS BOOKPersonalized Management of Gastric Cancer

This book offers essential information on basic and translational research in gastric cancer, while also illustrating potential opportunities for its application in clinical practice. Gastric cancer is the fourth-most-common cancer globally and the second-leading cause of cancer deaths. It is known to be a heterogeneous disease with varied responses to “one-size-fits-all” treatments. Expanding our knowledge of cancer cell genetics may help us to explore more effective treatments in gastric cancer. The research on molecular mechanisms and its clinical applications, both

Molecular Diagnostics

Molecular Diagnostics
  • Author : Jan Trost Jorgensen,Henrik Winther
  • Publisher : CRC Press
  • Release : 08 May 2019
GET THIS BOOKMolecular Diagnostics

This unique book provides a thorough overview of developing molecular cancer diagnostic assays, which are the prerequisites for optimal solutions within personalized cancer medicine. The book takes the reader through definitions of the pharmacodiagnostic concept, historical perspectives of the early steps into molecular cancer diagnostics linked to therapy, the basis of different diagnostic molecular techniques, ongoing research, drug-diagnostic co-development, assay validation, clinical trial methodology, regulatory issues around pharmacodiagnostics and future aspects within personalized cancer medicine.

Predictive Biomarkers in Oncology

Predictive Biomarkers in Oncology
  • Author : Sunil Badve,George Louis Kumar
  • Publisher : Springer
  • Release : 06 December 2018
GET THIS BOOKPredictive Biomarkers in Oncology

“Precision/personalized or stratified medicine” refers to the tailoring of medical treatment or drug administration to the individual characteristics of each patient treatment. It does not literally mean that a pharmaceutical company makes a drug for an individual patient for consumption and treatment but rather means the ability to stratify (or classify) individuals into sub-populations that differ in their responsiveness to a specific drug. A marker that provides information on the likely response to therapy, i.e., either in terms